By JERUSALEM POST STAFF As Moderna begins a late-stage trial of its coronavirus vaccine, chief medical officer Tal Zaks sold almost all his shares in the company, according…
By JERUSALEM POST STAFF As Moderna begins a late-stage trial of its coronavirus vaccine, chief medical officer Tal Zaks sold almost all his shares in the company, according…